ReviewDiabetology & metabolic syndrome2014

A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy.

Michelle Orme et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.